Triple
T680017
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Prévessin-Moëns |
E13160
|
entity |
| Predicate | sharesBorderWith |
P224
|
FINISHED |
| Object |
Versonnex
Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
|
E86127
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Versonnex | Statement: [Prévessin-Moëns, sharesBorderWith, Versonnex]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Versonnex Context triple: [Prévessin-Moëns, sharesBorderWith, Versonnex]
-
A.
Ornex
Ornex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
B.
Phenax
Phenax is a small genus of flowering plants in the hemp family Cannabaceae, native to the Americas and typically found in tropical to subtropical regions.
-
C.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
-
D.
Vuse
Vuse is an electronic cigarette and vaping product brand owned by British American Tobacco, known for its range of nicotine e-liquids and devices.
-
E.
Plegridy
Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Versonnex Triple: [Prévessin-Moëns, sharesBorderWith, Versonnex]
Generated description
Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Versonnex Target entity description: Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
A.
Ornex
Ornex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
B.
Phenax
Phenax is a small genus of flowering plants in the hemp family Cannabaceae, native to the Americas and typically found in tropical to subtropical regions.
-
C.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
-
D.
Vuse
Vuse is an electronic cigarette and vaping product brand owned by British American Tobacco, known for its range of nicotine e-liquids and devices.
-
E.
Plegridy
Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4933d3bf88190972041cd8cf143b9 |
completed | March 1, 2026, 7:27 p.m. |
| NER | Named-entity recognition | batch_69a4a04f4efc819082767a7517fa760a |
completed | March 1, 2026, 8:23 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a6374cc0d48190900e96a374ce35af |
completed | March 3, 2026, 1:20 a.m. |
| NEDg | Description generation | batch_69a637b4c578819086dd60ee6224ceef |
completed | March 3, 2026, 1:21 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a63860ec4c8190919115af097b9bfa |
completed | March 3, 2026, 1:24 a.m. |
Created at: March 1, 2026, 7:36 p.m.